VCBeat Health Contact Us
Home B. Braun Completes Full Acquisition of True Digital Surgery to Advance Robotic 3D Digital Microsurgery Platform

B. Braun Completes Full Acquisition of True Digital Surgery to Advance Robotic 3D Digital Microsurgery Platform

Sep 13, 2025 10:00 CST Updated 10:00
Aesculap

Surgical Medical Device Provider

B. Braun Announces Full Acquisition of True Digital Surgery (TDS), a Company Specializing in Digital Robotic-Assisted 3D Surgical Microscope Technology. This acquisition underscores B. Braun’s strategic investment in the future of digital microsurgery and its commitment to expanding market share in this growing sector.

Image

Prior to the acquisition, B. Braun already held a minority stake in TDS. This full acquisition will enable Aesculap, B. Braun’s surgical division, to acquire the core technological capabilities of the TDS team, ensuring the continued technological advancement of Aesculap AEOS (B. Braun’s flagship medical products for neurosurgery, spinal surgery, and ENT procedures).

Executive Evaluation

"This strategic move enables us to integrate TDS's cutting-edge technology and innovative capabilities. Through this powerful partnership, we will continue to provide customers with top-tier systems in the field of robot-assisted 3D microsurgery. The potential brought by this acquisition and the opportunities for further development of digital surgical solutions are exciting."

---Jens von Lackum  Member of the B. Braun Executive Board, Head of the Aesculap Division

“Merging with a highly respected healthcare company like B. Braun marks an exciting new milestone for True Digital Surgery and represents a natural extension of our successful multi-year partnership. Combining our breakthrough technologies with B. Braun’s global medical market resources will create unparalleled opportunities to improve the lives of patients and healthcare professionals worldwide.”

---Aidan Foley  Former CEO and Chairman of the Board of TDS

The high-end microsurgery market in the fields of neurosurgery, spine surgery, and otolaryngology is undergoing a significant transformation—shifting from traditional analog microscopes to digital exoscope systems. This new technology not only provides superior visualization at extreme angles, enabling surgeons to perform procedures via 3D monitors rather than eyepieces, but also allows them to maintain an upright posture, thereby effectively reducing physical strain.


RE3

RE3is a product of AesculapAesculap AEOS-like digital surgical microscope robot.RE3andThe Aesculap AEOS looks very similar, almost identical. BecauseAesculap AEOS is B. Braun andTDSCo-developed.

Image

According toTDS Introduction and DevelopmentRE3Reasons Based on Clinical Needs:

  • According to87% of neurosurgeons have experienced work-related musculoskeletal disorders

  • 19% of patients have degenerative lumbar disease, and the prevalence increases over time.

  • Compared with traditional surgical methods, the use of robotic exoscope technology significantly reduces surgeons' pain.

RE3 Advantages

  • More Ergonomically Designed Heads-Up Display

  • Real-Time High Dynamic Range Image Changes

  • 1:10 Scale

  • Working distance: 200–450 mm

  • Unparalleled Stability Platform

  • Reliable Locking Features

  • The surgeon-programmable memory mode provides the function to review previously interested areas.

  • Robotic-assisted motion provides superior stability for manually guided micromotions.


TDS
True Digital Surgery (TDS) specializes in digital robot-assisted 3D surgical microscopy technology. Leveraging a startup organizational structure and agile work model, TDS is dedicated to developing and integrating advanced technologies to enhance surgical precision and treatment outcomes.